4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with hemicholinium 3 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, A; Honda, K; Kamiya, H; Takano, Y | 1 |
| Chen, JT; Hsu, JH; Hsu, SF; Liou, SS; Liu, IM; Wu, YC | 1 |
2 other study(ies) available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and hemicholinium 3
| Article | Year |
|---|---|
Involvement of M3 muscarinic receptors of the spinal cord in formalin-induced nociception in mice.
Topics: Acetylcholine; Animals; Atropine; Cholinergic Agents; Cholinesterase Inhibitors; Formaldehyde; Hemicholinium 3; Male; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Neostigmine; Nociceptors; Pain; Pain Measurement; Piperidines; Receptor, Muscarinic M3; Receptors, Muscarinic; Spinal Cord | 2000 |
Release of acetylcholine by Die-Huang-Wan to enhance insulin secretion for lowering plasma glucose in Wistar rats.
Topics: Acetylcholine; Administration, Oral; Animals; Blood Glucose; Cholinergic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Chinese Herbal; Hemicholinium 3; Insulin; Insulin Secretion; Male; Muscarinic Antagonists; Neuromuscular Depolarizing Agents; Physostigmine; Piperidines; Rats; Rats, Wistar | 2002 |